Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
Saved in:
| Title: | Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02. |
|---|---|
| Authors: | Galanis E; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Anderson SK; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Miller CR; Pathobiology and Translational Science Graduate Program, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina., Sarkaria JN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Jaeckle K; Department of Neurology, Mayo Clinic, Jacksonville, Minnesota., Buckner JC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ballman KV; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Moore DF Jr; Department of Internal Medicine, Cancer Center of Kansas, Wichita, Kansas., Nebozhyn M; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, Pennsylvania., Loboda A; Data Analysis, Informatics & Analysis Department, Merck Research Laboratories, Boston, Massachusetts., Schiff D; Neuro-Oncology Center, University of Virginia School of Medicine, Charlottesville, Virginia., Ahluwalia MS; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gerstner ER; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts., Lesser GJ; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Prados M; Department of Neurological Surgery, University of California San Francisco, San Francisco, California., Grossman SA; Department of Oncology, Medicine & Neurosurgery, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Cerhan J; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Giannini C; Department of Pathology, Mayo Clinic, Rochester, Minnesota., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. |
| Corporate Authors: | Alliance for Clinical Trials in Oncology and ABTC |
| Source: | Neuro-oncology [Neuro Oncol] 2018 Mar 27; Vol. 20 (4), pp. 546-556. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
